Olavio R Baricordi
Overview
Explore the profile of Olavio R Baricordi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
569
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Campioni D, Bortolotti D, Baricordi O, Rizzo R
Haematologica
. 2013 Sep;
98(9):e114.
PMID: 24006410
No abstract available.
3.
Rizzo R, Bortolotti D, Baricordi O, Fainardi E
Inflamm Allergy Drug Targets
. 2012 Aug;
11(6):448-63.
PMID: 22931388
Human leucocyte antigen-G (HLA-G) is a non-classical HLA class I molecule with an important role at the fetus-maternal interface, preventing fetus recognition and abortion. The role of HLA-G as an...
4.
Rizzo R, Bortolotti D, Ben Fredj N, Rotola A, Cura F, Castellazzi M, et al.
Hum Immunol
. 2012 Aug;
73(11):1140-6.
PMID: 22922127
HLA-G is believed to act as an anti-inflammatory molecule in Multiple Sclerosis (MS). The 3' untranslated region of the HLA-G gene is characterized by two polymorphisms, DEL/INS14bp and +3142C>G, which...
5.
Buzzi M, Alviano F, Campioni D, Stignani M, Melchiorri L, Rotola A, et al.
Hum Immunol
. 2011 Dec;
73(2):150-5.
PMID: 22178696
Human umbilical cord blood units (UCBs) are an alternative source in allogeneic-stem-cell transplantation. Human leukocyte antigen (HLA)-G is a tolerogenic molecule with a possible implication in UCB immunoregulatory effect. HLA-G...
6.
Rizzo R, Quintavalle S, Stignani M, Franze F, Melchiorri L, De Rosa E, et al.
Environ Toxicol Pharmacol
. 2011 Jul;
27(2):303-5.
PMID: 21783957
HLA-G antigens are non-classical HLA-class I anti-inflammatory molecules. Since styrene exposure has been suggested to induce immune alteration, we analyzed plasma levels and "in vitro" peripheral blood mononuclear cell (PBMC)...
7.
Rizzo R, Lanzoni G, Stignani M, Campioni D, Alviano F, Ricci F, et al.
Cytotherapy
. 2010 Dec;
13(5):523-7.
PMID: 21171826
Background Aims: The beneficial activity of mesenchymal stromal cells (MSC) in allogeneic hematopietic stem cell transplantation requires correct use in terms of cell dose and timing of infusion and the...
8.
Rizzo R, Spaggiari F, Indelli M, Lelli G, Baricordi O, Rimessi P, et al.
Breast Cancer Res Treat
. 2010 Jul;
124(2):593-8.
PMID: 20632082
Taxanes represent a group of anticancer drugs with a wide range of activity against breast cancer. Therapy side effects include haematologic toxicity (neutropenia, leucopenia), peripheral neuropathy and hypersensitivity, and demonstrate...
9.
Ongaro A, Stignani M, Pellati A, Melchiorri L, Massari L, Caruso G, et al.
Hum Immunol
. 2010 Jan;
71(4):342-50.
PMID: 20097242
Human leukocyte antigen (HLA)-G molecules are nonclassical HLA class I antigens expressed as membrane bound and soluble isoforms (sHLA-G) with a restricted tissue distribution and anti-inflammatory functions. Because inflammation is...
10.
Rizzo R, Andersen A, Lassen M, Sorensen H, Bergholt T, Larsen M, et al.
Am J Reprod Immunol
. 2009 Oct;
62(5):320-38.
PMID: 19811467
Problem: Human Leukocyte Antigen (HLA)-G is a class Ib gene located in the human major histocompatibility complex (MHC). Several lines of investigation indicate that the HLA-G molecule is involved in...